PROTAC IRAK4 degrader-4 is primarily used in targeted protein degradation research. It is designed to selectively degrade IRAK4, a kinase involved in immune signaling pathways, particularly in inflammatory responses and cancer. This compound is utilized in preclinical studies to investigate the role of IRAK4 in diseases like lymphoma, autoimmune disorders, and chronic inflammation. By degrading IRAK4, it helps researchers understand its biological functions and evaluate its potential as a therapeutic target. Additionally, it serves as a tool to explore the efficacy of PROTAC technology in degrading disease-causing proteins, paving the way for novel treatment strategies.